Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 73% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money

73% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

  • Updates
  • cannabis

Is it time for tired investors to go all in on cannabis stocks?

One of those industries that never quite lived up to the hype, cannabis stocks rose ‘higher’ on Wednesday as the House set about discussing federal legalisation.

What does this mean for cannabis stocks?

This article was originally written by MyWallSt. Read more insights from the MyWallSt team here.

Are cannabis stocks the next big thing?

Hold your horses there pal, as mentioned above, this industry has been talked up for years now, yet failed to deliver impressive shareholder returns. Major players such as Aurora Cannabis [ACB], Sundial [SNDL] and OrganiGram are in the red in recent years.

However, the legalisation of weed in the US at a federal level could be a massive boon for the industry. With recreational marijuana use legal in just 18 states out of 50 — 38 states allow medicinal usage — this would create a massive amount of opportunity for the estimated $28.3bn weed industry in the US.

The House Rules Committee hearing is related to a proposed bill — better known as the MORE Act — which would legalise recreational usage on a federal level and also create provisions for banking and consumer packaged goods sales. Basically, it would allow banks across the US to do business with cannabis businesses, opening up a host of new funding and trade opportunities.

It’s a bit of a no-brainer really from a certain perspective, as there could be serious money for the federal government to make from the MORE Act. California, one of the first states to legalise marijuana use recreationally, generated more than $1bn in marijuana tax revenue just two years after state-wide legalisation. Legal cannabis sales are projected to reach $40.5bn by 2025. Likewise, the aforementioned businesses in this sector will be able to expand and grow nationwide with little regulatory issue.

However, the bill is expected to meet strong opposition in the Senate. The measure is expected to head to the full House for a vote Friday. Should it pass, investors might have a real opportunity on their hands.

 

MyWallSt gives you access to over 100 stock picks, as well as providing free analysis, multiple podcasts, customised market updates straight to your phone, and much more. Sign up for free today.

 

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

  • Includes free newsletter updates, unsubscribe anytime. Privacy policy

Latest articles